.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Teva
Baxter
Daiichi Sankyo
McKesson
Harvard Business School
Colorcon
Boehringer Ingelheim
US Army
Cipla

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050638

« Back to Dashboard
NDA 050638 describes PENICILLIN G POTASSIUM IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from one supplier. Additional details are available on the PENICILLIN G POTASSIUM IN PLASTIC CONTAINER profile page.

The generic ingredient in PENICILLIN G POTASSIUM IN PLASTIC CONTAINER is penicillin g potassium. There are eighty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.

Summary for NDA: 050638

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050638

Ingredient-typePenicillins

Suppliers and Packaging for NDA: 050638

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
penicillin g potassium
INJECTABLE;INJECTION 050638 NDA Baxter Healthcare Corporation 0338-1021 0338-1021-41 50 mL in 1 BAG (0338-1021-41)
PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
penicillin g potassium
INJECTABLE;INJECTION 050638 NDA Baxter Healthcare Corporation 0338-1023 0338-1023-41 50 mL in 1 BAG (0338-1023-41)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20,000 UNITS/ML
Approval Date:Jun 25, 1990TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength40,000 UNITS/ML
Approval Date:Jun 25, 1990TE:RLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength60,000 UNITS/ML
Approval Date:Jun 25, 1990TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Teva
Federal Trade Commission
Harvard Business School
Dow
McKesson
Fuji
Queensland Health
Farmers Insurance
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot